These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5392487)

  • 1. Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.
    Inagaki A; Nakamura T; Wakisaka G
    Cancer Res; 1969 Dec; 29(12):2169-76. PubMed ID: 5392487
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective toxicity of rifamycin derivatives for leukaemic human leucocytes.
    Smith RG; Whang-Peng J; Gallo RC; Levine P; Ting RC
    Nat New Biol; 1972 Apr; 236(67):1166-71. PubMed ID: 4503730
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
    Creasey WA; DeConti RC; Kaplan SR
    Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of DNA synthesis in peripheral leukemic cells by cytosine-arabinoside; attempt at deriving therapeutic application].
    Schleusner A; Schütt M; Langen P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):218-25. PubMed ID: 6168530
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticancer effects of propanals: comparison between human and animal tumor systems.
    Apple MA; Cline MJ
    Natl Cancer Inst Monogr; 1971 Dec; 34():161-5. PubMed ID: 5140861
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
    Graham FL; Whitmore GF
    Cancer Res; 1970 Nov; 30(11):2636-44. PubMed ID: 5530558
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
    Wilmanns W
    Natl Cancer Inst Monogr; 1971 Dec; 34():153-9. PubMed ID: 5291099
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
    Chou TC; Burchenal JH; Schmid FA; Braun TJ; Su TL; Watanabe KA; Fox JJ; Philips FS
    Cancer Res; 1982 Oct; 42(10):3957-63. PubMed ID: 7104996
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyrimidine metabolism in human leukocytes. I. Contribution of exogenous thymidine to DNA-thymine and its effect on thymine nucleotide synthesis in leukemic leukocytes.
    Cooper RA; Perry S; Breitman TR
    Cancer Res; 1966 Nov; 26(11):2267-75. PubMed ID: 5225414
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract]   [Full Text] [Related]  

  • 11. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA synthesis of leukemic leukocytes].
    Rainer H; Piller G; Moser K
    Verh Dtsch Ges Inn Med; 1973; 79():383-7. PubMed ID: 4790238
    [No Abstract]   [Full Text] [Related]  

  • 13. On the characteristics of inhibition of deoxyribonucleic acid synthesis by 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine.
    Kessel D
    Biochem Pharmacol; 1974 Oct; 23(19):2657-62. PubMed ID: 4420738
    [No Abstract]   [Full Text] [Related]  

  • 14. A micro-system for screening anti-leukemic drugs utilizing human whole blood.
    Farrow MG; Van Dyke K
    Chemotherapy; 1971; 16(2):76-84. PubMed ID: 5120611
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
    Li LH; Olin EJ; Buskirk HH; Reineke LM
    Cancer Res; 1970 Nov; 30(11):2760-9. PubMed ID: 5487063
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of in vivo cytotoxicity of chemotherapeutic agents by their in vitro effect on leukocytes from patients with acute leukemia.
    Cline MJ; Rosenbaum E
    Cancer Res; 1968 Dec; 28(12):2516-21. PubMed ID: 5248517
    [No Abstract]   [Full Text] [Related]  

  • 17. Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
    Shackney SE; Ford SS; Occhipinti SJ; Ritch PS; Riccardi R; Erickson BW
    Cancer Res; 1982 Nov; 42(11):4339-47. PubMed ID: 7127279
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
    Hoshi A; Kanzawa F; Kuretani K; Kanai T; Ichino M
    Biochem Pharmacol; 1973 Nov; 22(22):2829-34. PubMed ID: 4761553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemical basis of the treatment of leukemia with cytosine-arabinoside].
    Wilmanns H
    Schweiz Med Wochenschr; 1970 Feb; 100(7):323-5. PubMed ID: 5413922
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine.
    Veselý J; Cihák A; Sorm F
    Cancer Res; 1970 Aug; 30(8):2180-6. PubMed ID: 5459765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.